Results
73,241 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Atay OguzhanDirector, Chairman and CEO |  BLLNBillionToOne, Inc.Option exercise · 10b5-1 plan | M | $47K 16.7K sh | Nov 4, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Atay OguzhanDirector, Chairman and CEO | BLLNBillionToOne, Inc. Option exercise · 10b5-1 plan | M | $47K 16.7K sh | Nov 4, 2026 |
| 0 | Santana RafaelDirector, President and CEO |  WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORPOpen-market sale · 10b5-1 plan | SELL | $19K 66 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner |  IBTAIbotta, Inc.Option exercise · 10b5-1 plan | M | $442K 34.7K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Wampler Kira SchererDirector |  DOCSDoximity, Inc.Derivative conversion · 10b5-1 plan | C | — 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Krasnow ToddDirector |  SYMSymbotic Inc.Other acquisition or disposition · 10b5-1 plan | J | — 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Wampler Kira SchererDirector | DOCSDoximity, Inc. Option exercise · 10b5-1 plan | M | — 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Krasnow ToddDirector | SYMSymbotic Inc. Other acquisition or disposition · 10b5-1 plan | J | — 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Hall John TDirector, Chief Executive Officer |  INTAIntapp, Inc.Option exercise · 10b5-1 plan | M | — 3,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Tsuchimoto Kim RDirector |  MNPRMonopar TherapeuticsOption exercise · 10b5-1 plan | M | $26K 856 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 0 | Raabe Kyle AndrewPresident, Home Power Gen. |  GNRCGENERAC HOLDINGS INC.Option exercise · 10b5-1 plan | M | — 212 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 0 | Tsuchimoto Kim RDirector | MNPRMonopar Therapeutics Option exercise · 10b5-1 plan | M | $36K 1,199 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Anderson RaymondDirector | MNPRMonopar Therapeutics Option exercise · 10b5-1 plan | M | — 1,402 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Daunt JohnEVP, Chief Commercial Officer |  LQDTLIQUIDITY SERVICES INCOption exercise · 10b5-1 plan | M | $8,432 390 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Daunt JohnEVP, Chief Commercial Officer | LQDTLIQUIDITY SERVICES INC Option exercise · 10b5-1 plan | M | — 390 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 |  Silbermann BenjaminDirector, 10% Owner |  PINSPINTEREST, INC.Derivative conversion · 10b5-1 plan | C | — 46.9K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 0 | Bertolini JeffreyChief Operating Officer |  CARLCARLSMED, INC.Option exercise · 10b5-1 plan | M | — 747 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Derivative conversion · 10b5-1 plan | C | — 2,620 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Silbermann BenjaminDirector, 10% Owner | PINSPINTEREST, INC. Derivative conversion · 10b5-1 plan | C | — 46.9K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 0 | Reardon AndrewCLO & Secretary |  LGNDLIGAND PHARMACEUTICALS INCOption exercise · 10b5-1 plan | M | — 5,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Hall John TDirector, Chief Executive Officer | INTAIntapp, Inc. Option exercise · 10b5-1 plan | M | $22K 3,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Anderson RaymondDirector | MNPRMonopar Therapeutics Option exercise · 10b5-1 plan | M | — 1,740 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Bertolini JeffreyChief Operating Officer | CARLCARLSMED, INC. Option exercise · 10b5-1 plan | M | $4,419 747 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 0 | Costello Beth AnnEVP and CFO |  HIGHARTFORD INSURANCE GROUP, INC.Option exercise · 10b5-1 plan | M | — 31.6K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Santana RafaelDirector, President and CEO | WABWESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP Open-market sale · 10b5-1 plan | SELL | $46K 158 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 0 | Atay OguzhanDirector, Chairman and CEO | BLLNBillionToOne, Inc. Option exercise · 10b5-1 plan | M | $47K 16.7K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Comly Barbara J.EVP, GC & Corporate Secretary |  MIAXMIAMI INTERNATIONAL HOLDINGS, INC.Option exercise · 10b5-1 plan | M | — 8,799 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 0 | Fukushima RyanCEO, Data |  TEMTempus AI, Inc.Grant or award · 10b5-1 plan | A | — 100.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Option exercise · 10b5-1 plan | M | $38K 4,529 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 0 | Ticho BarryCHIEF MEDICAL OFFICER |  STOKStoke Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $5,398 200 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Option exercise · 10b5-1 plan | M | $48K 5,751 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Cowan ElviaSVP, Finance & CAO |  PCVXVaxcyte, Inc.Option exercise · 10b5-1 plan | M | $78K 3,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Syrvalin Kristine CEVP General Counsel |  MTUSMetallus Inc.Option exercise · 10b5-1 plan | M | $52.38 3 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Vassil JonathanChief Revenue Officer |  TOSTToast, Inc.Option exercise · 10b5-1 plan | M | — 14.3K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Krasnow ToddDirector | SYMSymbotic Inc. Other acquisition or disposition · 10b5-1 plan | J | — 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Nithrakashyap ArvindDirector, Chief Technology Officer |  RBRKRubrik, Inc.Derivative conversion · 10b5-1 plan | C | — 12.8K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 0 | Houston AndrewDirector, Co-CEO, 10% Owner |  DBXDROPBOX, INC.Derivative conversion · 10b5-1 plan | C | — 383.8K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Raabe Kyle AndrewPresident, Home Power Gen. | GNRCGENERAC HOLDINGS INC. Option exercise · 10b5-1 plan | M | $22K 212 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 0 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Derivative conversion · 10b5-1 plan | C | — 2,620 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Cowan ElviaSVP, Finance & CAO | PCVXVaxcyte, Inc. Option exercise · 10b5-1 plan | M | — 3,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 0 | Houston AndrewDirector, Co-CEO, 10% Owner | DBXDROPBOX, INC. Derivative conversion · 10b5-1 plan | C | — 383.8K sh | Nov 4, 2026 traded Nov 2, 2026 |